Weida Tong

1.
Xi Chen, Ting Li, Weida Tong, Minjun Chen. Chapter 7 - The application of generative adversarial networks (GANs) as new approach methods (NAMs) toward nonanimal testing. In: Catharine E. Krebs, Gail A. Van Norman, eds. Moving Toward Nonanimal Approaches in Medical Research and Testing. Academic Press; 2027:105-119. https://www.sciencedirect.com/science/article/pii/B9780443265143000199.
View Full Reference
1.
Thomas Hartung, Maurice Whelan, Weida Tong, Robert M. Califf. Is regulatory science ready for artificial intelligence? npj Digital Medicine. 2025;8(1):1-5. doi:10.1038/s41746-025-01596-0
View Full Reference
1.
Shivangi Shrimali, Minjun Chen, Dongying Li, Weida Tong. New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now? Drug Discovery Today. 2025:104452. doi:10.1016/j.drudis.2025.104452
View Full Reference
1.
Shivangi Shrimali, Minjun Chen, Dongying Li, Weida Tong. New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now? Drug Discovery Today. 2025;30(9):104452. doi:10.1016/j.drudis.2025.104452
View Full Reference
1.
Gro H. Mathisen, Angela Bearth, Lowenna B. Jones, et al. Time for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology. Archives of Toxicology. 2024;98(8):2299-2308. doi:10.1007/s00204-024-03802-6
View Full Reference